New Zealand markets closed

Eurofins Scientific SE (ERFSF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
62.72+1.03 (+1.67%)
As of 03:49PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 11.94B
Enterprise value 14.87B
Trailing P/E 36.86
Forward P/E 19.42
PEG ratio (5-yr expected) 1.22
Price/sales (ttm)1.76
Price/book (mrq)2.19
Enterprise value/revenue 2.28
Enterprise value/EBITDA 12.22

Trading information

Stock price history

Beta (5Y monthly) 0.60
52-week change 3-6.50%
S&P500 52-week change 329.57%
52-week high 372.39
52-week low 347.14
50-day moving average 360.61
200-day moving average 360.43

Share statistics

Avg vol (3-month) 31.45k
Avg vol (10-day) 31.81k
Shares outstanding 5191.97M
Implied shares outstanding 6192.97M
Float 8129.48M
% held by insiders 132.72%
% held by institutions 137.33%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.09
Forward annual dividend yield 41.73%
Trailing annual dividend rate 30.50
Trailing annual dividend yield 30.81%
5-year average dividend yield 4N/A
Payout ratio 463.69%
Dividend date 3N/A
Ex-dividend date 405 Jul 2023
Last split factor 210:1
Last split date 319 Nov 2020

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 4.76%
Operating margin (ttm)11.52%

Management effectiveness

Return on assets (ttm)4.27%
Return on equity (ttm)6.16%

Income statement

Revenue (ttm)6.51B
Revenue per share (ttm)33.77
Quarterly revenue growth (yoy)0.10%
Gross profit (ttm)N/A
EBITDA 1.19B
Net income avi to common (ttm)256.5M
Diluted EPS (ttm)1.70
Quarterly earnings growth (yoy)-47.20%

Balance sheet

Total cash (mrq)1.23B
Total cash per share (mrq)6.36
Total debt (mrq)3.93B
Total debt/equity (mrq)76.43%
Current ratio (mrq)1.45
Book value per share (mrq)21.14

Cash flow statement

Operating cash flow (ttm)1.02B
Levered free cash flow (ttm)511.9M